US 8497279
Treatment for discoid lupus
granted A61KA61K31/505A61K45/06
Quick answer
US patent 8497279 (Treatment for discoid lupus) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/505, A61K45/06, A61K9/0014, A61P